Invitrogen™ Human MINA53 Synthetic Peptide

Ref.: BL-RE-175927Manufacturer ref.: PEP-1023 50 μg
€149.00 excl. VAT

MINA Synthetic Peptide, PEP-1023, from Invitrogen.

Gene ID (Enter)
84864
Species
Human
Purification method
Purified
Accession number
Q8IUF8
Common name
Human MINA53
Brand
Invitrogen

MINA Synthetic Peptide, PEP-1023, from Invitrogen.

MINA Synthetic Peptide, PEP-1023, from Invitrogen.

MINA is nuclear localized, myc-inducible protein that is thought to play a role in mammalian cell proliferation. Treatment of cancer cells lines such as the colon cancer cell line SW680 with siRNA against MINA inhibits cell growth, demonstrating that MINA may be a potential therapeutic target. MINA regulates several genes related to cell adhesion and metabolism that have also been shown to be regulated by c-Myc, but also regulates other genes whose expression are not modulated by c-Myc such as EGFR, IL-6 and HGF. MINA has also been found to act as a repressor to IL-4 expression in T cells, indicating that it may also play a role in T cell differentiation and genetic variation in T helper type 2 bias.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15295019
Specifications
Gene ID (Enter)84864
SpeciesHuman
Purification methodPurified
Accession numberQ8IUF8
Common nameHuman MINA53
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)RIOX2
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1023
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.